Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 511

1.

Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.

Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR.

Mod Pathol. 2005 Apr;18(4):475-84.

2.

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.

Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, Hagemeijer A, Sciot R.

Mod Pathol. 2004 Aug;17(8):889-94.

3.

Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P.

Clin Cancer Res. 2008 Jul 15;14(14):4550-5. doi: 10.1158/1078-0432.CCR-08-0086.

4.

Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland.

Tryggvason G, Hilmarsdottir B, Gunnarsson GH, Jónsson JJ, Jónasson JG, Magnússon MK.

APMIS. 2010 Sep 1;118(9):648-56. doi: 10.1111/j.1600-0463.2010.02643.x.

PMID:
20718716
5.

Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.

Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K, Chayama K.

Int J Mol Med. 2006 Dec;18(6):1067-71.

PMID:
17089009
6.

Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.

Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM.

Am J Surg Pathol. 2007 Feb;31(2):224-32.

PMID:
17255767
7.

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Miettinen M, Sobin LH, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

PMID:
19440146
8.

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).

Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.

J Surg Oncol. 2008 Sep 1;98(3):175-8. doi: 10.1002/jso.21104.

PMID:
18618605
9.

Mutations in gastrointestinal stromal tumors--a population-based study from Northern Norway.

Steigen SE, Eide TJ, Wasag B, Lasota J, Miettinen M.

APMIS. 2007 Apr;115(4):289-98.

PMID:
17504295
10.

Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, Yokoyama S, Motegi A, Fukayama M.

Am J Surg Pathol. 2005 Jun;29(6):755-63.

PMID:
15897742
11.
12.

The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G.

J Clin Pathol. 2005 Jun;58(6):634-9.

13.

[c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].

Beliakov IS, Anurova OA, Snigur PV, Tsyganova IV, Sel'chuk VIu, Mazurenko NN.

Vopr Onkol. 2007;53(6):677-81. Russian.

PMID:
18416137
14.

An immunohistochemical and molecular study of gastrointestinal stromal tumours.

Teong YT, Teo ST, Tan LP, Wu BQ, Peh SC.

Med J Malaysia. 2006 Dec;61(5):526-33.

15.

PKCtheta expression in gastrointestinal stromal tumor.

Kim KM, Kang DW, Moon WS, Park JB, Park CK, Sohn JH, Jeong JS, Cho MY, Jin SY, Choi JS, Kang DY.

Mod Pathol. 2006 Nov;19(11):1480-6. Epub 2006 Aug 4.

16.

[Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].

Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Jul;11(4):371-5. Chinese.

PMID:
18636362
17.

Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.

de Raedt T, Cools J, Debiec-Rychter M, Brems H, Mentens N, Sciot R, Himpens J, de Wever I, Schöffski P, Marynen P, Legius E.

Gastroenterology. 2006 Dec;131(6):1907-12.

PMID:
17087943
18.

Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.

Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K, Chayama K.

Int J Oncol. 2006 Jun;28(6):1361-7.

PMID:
16685437
19.

Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.

Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS.

Anticancer Res. 2012 Mar;32(3):923-37.

PMID:
22399613
20.

KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.

Am J Surg Pathol. 2011 Sep;35(9):1287-95. doi: 10.1097/PAS.0b013e3182206f15.

PMID:
21836495

Supplemental Content

Support Center